John Overdeck’s Global Blood Therapeutics, Inc. GBT Stock Holding History

John Overdeck’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-314,839	Closed	-$21.4M	–	3232
2022 Q3	$21.4M	Buy	314,839 +144,041	+84%	+$7.94M	0.07%	308
2022 Q2	$5.46M	Sell	170,798 -267,282	-61%	-$7.82M	0.02%	733
2022 Q1	$15.2M	Buy	438,080 +246,575	+129%	+$7.37M	0.04%	464
2021 Q4	$5.61M	Buy	+191,505	New	+$5.93M	0.01%	1127
2020 Q1	–	Sell	-171,922	Closed	-$13.7M	–	4020
2019 Q4	$13.7M	Buy	+171,922	New	+$10.2M	0.04%	499

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

John Overdeck's GBT Position: Q4 2022 in Review

John Overdeck sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 314,839 shares — an estimated $21.4M sold.

John Overdeck first reported a position in GBT in Q4 2019 and held it in 5 quarters. The position peaked at $21.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

John Overdeck reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
John Overdeck sold 314,839 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $21.4M.
John Overdeck first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 5 quarters.
John Overdeck's Global Blood Therapeutics, Inc. position peaked at $21.4M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.